A carregar...
Therapeutic Antibodies for the Treatment of Pancreatic Cancer
Pancreatic cancer is a devastating disease with the worst mortality rate and an overall 5-year survival rate lower than 5%. In the U.S., this disease is the fourth leading cause of death and represents 6% of all cancer-related deaths. Gemcitabine, the current standard first-line treatment, offers ma...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
TheScientificWorldJOURNAL
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2925140/ https://ncbi.nlm.nih.gov/pubmed/20563534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/tsw.2010.103 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|